SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 2.31 |
| Enterprise Value ($M) | -5.50 |
| Book Value ($M) | 6.61 |
| Book Value / Share | 2.39 |
| Price / Book | 0.35 |
| NCAV ($M) | 6.14 |
| NCAV / Share | 2.22 |
| Price / NCAV | 0.38 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.02 |
| Return on Assets (ROA) | -1.00 |
| Return on Equity (ROE) | -1.24 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.31 |
| Current Ratio | 3.31 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 8.87 |
| Assets | 9.34 |
| Liabilities | 2.73 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 9.99 | 127.08 | |
| 13G/A | Lind Global Fund II LP | 1.70 | -78.70 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 45,535 | 97,233 | 46.83 | |
| 10,325 | 33,124 | 31.17 | |
| 5,446 | 16,249 | 33.52 | |
| 4,680 | 45,872 | 10.20 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ORGO – Organogenesis Holdings Inc. | ORMP – Oramed Pharmaceuticals Inc. |
| OTLK – Outlook Therapeutics, Inc. | PASG – Passage Bio, Inc. |
| PCSA – Processa Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io